Metric Analysis: Exact Sciences Corp. (EXAS)’s Key Ratios in the Limelight

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

In the latest session, Exact Sciences Corp. (NASDAQ: EXAS) closed at $55.59 up 3.89% from its previous closing price of $53.51. In other words, the price has increased by $3.89 from its previous closing price. On the day, 2.7 million shares were traded. EXAS stock price reached its highest trading level at $55.77 during the session, while it also had its lowest trading level at $53.58.

Ratios:

For a deeper understanding of Exact Sciences Corp.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.72.

On December 14, 2023, Guggenheim started tracking the stock assigning a Buy rating and target price of $90.

On December 13, 2023, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.Wolfe Research initiated its Outperform rating on December 13, 2023, with a $95 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 01 ’24 when Conroy Kevin T sold 1,155 shares for $60.15 per share. The transaction valued at 69,473 led to the insider holds 1,156,191 shares of the business.

Cunningham Everett sold 136 shares of EXAS for $8,180 on May 01 ’24. The Chief Commercial Officer now owns 47,042 shares after completing the transaction at $60.15 per share. On May 01 ’24, another insider, Elliott Jeffrey Thomas, who serves as the Chief Financial Officer of the company, sold 136 shares for $60.15 each. As a result, the insider received 8,180 and left with 11,795 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 10258022400 and an Enterprise Value of 12180659200. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.05 while its Price-to-Book (P/B) ratio in mrq is 3.26. Its current Enterprise Value per Revenue stands at 4.805 whereas that against EBITDA is -112.323.

Stock Price History:

Over the past 52 weeks, EXAS has reached a high of $100.77, while it has fallen to a 52-week low of $52.25. The 50-Day Moving Average of the stock is -12.13%, while the 200-Day Moving Average is calculated to be -18.54%.

Shares Statistics:

For the past three months, EXAS has traded an average of 2.72M shares per day and 3565820 over the past ten days. A total of 184.53M shares are outstanding, with a floating share count of 182.61M. Insiders hold about 1.04% of the company’s shares, while institutions hold 82.73% stake in the company. Shares short for EXAS as of 1714435200 were 8876441 with a Short Ratio of 3.27, compared to 1711584000 on 6339844. Therefore, it implies a Short% of Shares Outstanding of 8876441 and a Short% of Float of 4.8699997.

Most Popular

[the_ad id="945"]